Nealbarbital
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 5-allyl-5-(1,1-dimethylpropyl)pyrimidine-2,4,6(1H,3H,5H)-trione | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 561-83-1 |
| ATC code | None |
| PubChem | CID 521716 |
| ChemSpider | 455089  |
| UNII | 25ATP958PA |
| Synonyms | Nealbarbital, Censedal |
| Chemical data | |
| Formula | C12H18N2O3 |
| Mol. mass | 238.28 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
Nealbarbital (Censedal) is a barbiturate derivative developed by Aktiebolaget Pharmacia in the 1950s[1]. It has sedative and hypnotic effects, and was used for the treatment of insomnia.
[edit] References
- ^ US Patent 2899435
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
